Medical Device | February 13, 2023
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
91% of cloud leaders expect their cloud capabilities to be largely centralized within the next 2 years and 64% of cloud leaders have realized cybersecurity cost savings by migrating to cloud
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Cell sorting technology supports researchers advancing new therapies
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
Point-of-Care solution to facilitate clinicians in quick and effective decision making
Subscribe To Our Newsletter & Stay Updated
